LinkedIn Profile

Access Retia Medical historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:retiamedical 2587771 May 26th, 2020 12:00AM Retia Medical 333 7.00 Open Medical Device May 26th, 2020 12:42PM May 26th, 2020 12:42PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 25th, 2020 12:00AM Retia Medical 332 7.00 Open Medical Device May 25th, 2020 12:27PM May 25th, 2020 12:27PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 24th, 2020 12:00AM Retia Medical 331 7.00 Open Medical Device May 24th, 2020 05:20PM May 24th, 2020 05:20PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 23rd, 2020 12:00AM Retia Medical 331 7.00 Open Medical Device May 23rd, 2020 07:32PM May 23rd, 2020 07:32PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 22nd, 2020 12:00AM Retia Medical 330 7.00 Open Medical Device May 22nd, 2020 06:57PM May 22nd, 2020 06:57PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 21st, 2020 12:00AM Retia Medical 327 7.00 Open Medical Device May 21st, 2020 04:54PM May 21st, 2020 04:54PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 20th, 2020 12:00AM Retia Medical 326 7.00 Open Medical Device May 20th, 2020 07:29PM May 20th, 2020 07:29PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 19th, 2020 12:00AM Retia Medical 322 7.00 Open Medical Device May 19th, 2020 01:56PM May 19th, 2020 01:56PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 18th, 2020 12:00AM Retia Medical 319 7.00 Open Medical Device May 18th, 2020 03:50PM May 18th, 2020 03:50PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services
private:retiamedical 2587771 May 17th, 2020 12:00AM Retia Medical 316 7.00 Open Medical Device May 17th, 2020 05:49PM May 17th, 2020 05:49PM Retia Medical is a venture-funded startup backed by the Pritzker-Vlock family office. Retia’s first product is a patient monitor (The Argos) for tracking cardiac output (blood flow rate). The initial interest for this technology is the ICU and operating rooms. Approximately 15 million surgical patients and 3 million intensive care patients worldwide could benefit from this technology. Based in Valhalla, NY, Retia’s technology was developed at Michigan State University and Massachusetts Institute of Technology and validated through extensive tests in animals and humans. With the support of a strong advisory board comprised of industry and clinical experts, Retia received FDA 510(k) clearance and launched this product in December 2018, which will help revolutionize the care of the most at-risk patients. Open Patient Monitoring, Signal Processing, Cardiovascular, Software, Digital Health, Hemodynamics, Critical Care Medicine, Cardiac Output Open 7 Dana Rd Valhalla New York US 10595 Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.